Japanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Zeria Pharmaceutical

Market Cap: JP¥92.2b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

NANO MRNALtd

Market Cap: JP¥9.5b

Researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan.

SymBio Pharmaceuticals

Market Cap: JP¥6.8b

Engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally.

RaQualia Pharma

Market Cap: JP¥14.1b

Engages in the research and development of pharmaceutical compounds worldwide.

D. Western Therapeutics Institute

Market Cap: JP¥7.2b

A biotechnology company, focuses on discovery and development of various drugs.

Linical

Market Cap: JP¥7.9b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

Human Metabolome Technologies

Market Cap: JP¥4.2b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Hisamitsu Pharmaceutical

Market Cap: JP¥297.7b

Manufactures and sells pharmaceuticals in Japan.

Ono Pharmaceutical

Market Cap: JP¥801.7b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Cyfuse Biomedical K.K

Market Cap: JP¥4.9b

Engages in the development, manufacture, and sale of regenerative medicine products in Japan.

Chiome Bioscience

Market Cap: JP¥9.0b

Engages in the research and development of drug discovery technology platforms worldwide.

Seikagaku

Market Cap: JP¥37.1b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

Tsubota Laboratory

Market Cap: JP¥9.0b

Engages in the development and sale of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, presbyopia, and neurological disorders.

MedRx

Market Cap: JP¥6.9b

A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.

Japan Tissue Engineering

Market Cap: JP¥20.9b

Engages in the regenerative medicine business in Japan.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥67.7b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Daito PharmaceuticalLtd

Market Cap: JP¥37.4b

Manufactures and sells pharmaceutical products worldwide.

Kohjin Bio

Market Cap: JP¥8.2b

Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics.

Oncolys BioPharma

Market Cap: JP¥15.4b

Engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States.

Astena Holdings

Market Cap: JP¥21.5b

Manufactures and sells medicine-related products in Japan.

Kubota Pharmaceutical Holdings

Market Cap: JP¥4.0b

Develops portfolio of drugs and devices worldwide.

Takeda Pharmaceutical

Market Cap: JP¥6.9t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Pharma Foods International

Market Cap: JP¥24.3b

Engages in the development and sale of functional food ingredients in Japan.

PhoenixBio

Market Cap: JP¥1.7b

Provides contract study services for drug discovery and development primarily in Japan.

Eisai

Market Cap: JP¥1.5t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Astellas Pharma

Market Cap: JP¥3.0t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

AnGes

Market Cap: JP¥29.7b

Engages in the research and development of gene-based medical products.

GNI Group

Market Cap: JP¥135.4b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Delta-Fly Pharma

Market Cap: JP¥5.3b

Develops anticancer drugs.

KYORIN Pharmaceutical

Market Cap: JP¥87.3b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

Healios K.K

Market Cap: JP¥66.1b

Engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

PeptiDream

Market Cap: JP¥208.0b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

atect

Market Cap: JP¥2.0b

Engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses.

Fuji Pharma

Market Cap: JP¥38.3b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Nippon Chemiphar

Market Cap: JP¥6.0b

Engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally.